Drop in breast cancer incidence linked to hormone use, not mammograms

	Tweet

A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online August 14 in the Journal of the National Cancer Institute. It is more likely due to the drop in postmenopausal hormone use.

There has been a recent, rapid decline in postmenopausal hormone therapy use since 2002 when the Women’s Health Initiative study found that hormone therapy was associated with an increased risk of breast cancer.

Recent data has linked a decrease in breast cancer incidence over the last few years to this drop in hormone use, but this explanation remains controversial. Some researchers have said it is unclear whether the drop was related to the decline in hormone therapy use or a decrease in mammography screening over the same period.

Karla Kerlikowske, M.D., of the University of California, San Francisco and colleagues from the Breast Cancer Surveillance Consortium addressed this question by examining breast cancer rates in a population of women collected from seven mammography registries located in the U.S. who had received screening mammograms between 1997 and 2003. They collected data on over 600,000 mammograms performed on women ages 50 to 69. This is the first study to investigate breast cancer incidence and hormone therapy use in a population of women undergoing routine mammograms.

Between 2000 and 2003, use of hormone therapy among the study population declined—by 7 percent a year between 2000 and 2002, then by 34 percent a year between 2002 and 2003. Over the same period, breast cancer incidence rates declined annually by 5 percent. Estrogen-receptor positive breast cancer rates fell by 13 percent each year from 2001 to 2003.

“Our results suggest that a decline in postmenopausal hormone therapy use has contributed to the decline in breast cancer incidence in the United States and that the small decline in screening mammography observed in the United States is unlikely to explain the national declines in breast cancer incidence,” the authors write.

###

Contact: Steve Tokar, manager of communications, Northern California Institute for Research and Education, (415) 221-4810 x5202

Citations: Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA. Declines in Invasive Breast Cancer and Use of Postmenopausal Hormone Therapy in a Screening Mammography Population. J Natl Cancer Inst. 2007;99. 

RELATED STORIES:
NSAIDs could help prevent, treat breast cancer   New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks   No long-term cancer risk seen from breast implants   Mom should not hide her cancer from the kids   One daily glass of wine ‘can double risk of breast cancer’   A pill a day gives renewed hope for breast cancer victims   Current Status of Prognostic Profiling in Breast Cancer: study   Breast Cancer Statistics   Transparent Zebrafish Help Researchers Track Breast Cancer   Breast-feeding debate heats up in Massachusetts   Big Bias In Who Gets Screened for Breast Cancer   Genes, lifestyle pose separate breast cancer risks   New Clues to Breast Cancer Development in High-Risk Women   Breast Reconstruction Varies by Race   Overeating plus inactivity ups breast cancer risk   Prevennia Supplement Blocks the Initiation of Breast Cell Mutations by Estrogens   Smoking increased risk of death in women with breast cancer   Study aims to find which breast cancer patients need chemotherapy   Tamoxifen discontinuation rates surprisingly high in clinical practice   Smoking Did Not Influence Breast Cancer Risk Among Obese Women   Breast cancer deaths decline more slowly for some   Scientists developing breast cancer treatment test news

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]